Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Cytoreductive Treatment in 'Real Life' - Interim-Analysis of 434 Polycythemia Vera Patients in Germany

Carl C. Crodel, Kathleen Jentsch-Ulrich, MD, Lutz Jacobasch, Philipp Kiewe, Jens Kisro, Jörg Lipke, Siegfried W. Prenninger, Marcel Reiser, Regine Wunschel, Andreas Hochhaus, MD, Florian H. Heidel

Blood (2019) 134 (Supplement_1): 1672.

https://doi.org/10.1182/blood-2019-122681

Published: 2019

Journal Articles

Flow-Cytometry Based Detection of Any Minimal Residual Disease (FC-MRD) in Children with T-Acute Lymphoblastic Leukemias (T-ALL) Is a Powerful Indicator of Outcome

Prashant Tembhare, MD, Gaurav Narula, MD, Gaurav Chatterjee, MD, Twinkle Khanka, Mahima Sanyal, Sitaram Ghogale, Nikhil Patkar, MD, Nilesh Deshpande, Yajamanam Badrinath, Sumeet Gujral, MD, Shripad Banavali, MD, Papagudi Ganesan Subramanian, MD

Blood (2019) 134 (Supplement_1): 2585.

https://doi.org/10.1182/blood-2019-128347

Published: 2019

Journal Articles

Osteopontin Mediates Murine Transfusion-Related Acute Lung Injury through Stimulation of Pulmonary Neutrophil Accumulation

Rick Kapur, MDPhDMSc, Gopinath Kasetty, PhD, Johan Rebetz, PhD, Arne Egesten, MD PhD, John W Semple, PhD

Blood (2018) 132 (Supplement 1): 739.

https://doi.org/10.1182/blood-2018-99-115770

Published: 2018

Journal Articles

Observations from the First 1,000 Suspected aHUS Patients, Tested By a Rapid aHUS Genetic (NGS) Panel: Causative Genes Identified in a Subpopulation of Our Database

James Anderson-Furgeson, PhD, Jamey Kain, PhD, Sujatha Venkataramani, PhD, Jooeun Lim, PhD, Mike Ero, MT, CLS, MBA, Bradley Lewis, MD

Blood (2018) 132 (Supplement 1): 5017.

https://doi.org/10.1182/blood-2018-99-120308

Published: 2018

Journal Articles

Area-Based Socioeconomic Status and Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Outcomes: A CIBMTR Analysis

Kira O Bona, MDMPH, Ruta Brazauskas, PhD, Naya He, Leslie E. Lehmann, MD, Joanne Wolfe, MD MPH, Jignesh Dalal, MD, Shahrukh K. Hashmi, MDMPH, Theresa E. Hahn, PhD, Nandita Khera, MD, William A. Wood, MD MPH, Christine Duncan, MD MSc, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 714.

https://doi.org/10.1182/blood-2018-99-118544

Published: 2018

Journal Articles

Gastrointestinal Flora Dictates the Biological Response in Murine Transfusion Related Acute Lung Injury (TRALI)

Rick Kapur, MDPhDMSc, Michael Kim, BSc, Johan Rebetz, PhD, Alisa Takabe-French, Noel Kim, Shanjeevan Shanmugabhavananthan, BSc, Edwin R. Speck, BRT, John W Semple, PhD

Blood (2017) 130 (Supplement 1): 766.

https://doi.org/10.1182/blood.V130.Suppl_1.766.766

Published: 2017

Journal Articles

Development of a Dynamic Model for Personalized Risk Assessment in Large B-Cell Lymphoma

Blood (2017) 130 (Supplement 1): 826.

https://doi.org/10.1182/blood.V130.Suppl_1.826.826

Published: 2017

Journal Articles

Prevalence and Risk-Factors for Financial Burden in Patients with Chronic Graft-Versus-Host Disease: A Cross-Sectional Survey from the Chronic Gvhd Consortium

Nandita Khera, MD, Madan Jagasia, MD MBBS, MS, Raewyn Broady, MBChB, FRACP, Lynn E. Onstad, ScM, Betty K. Hamilton, MD, George Chen, MD, Amin M. Alousi, Stefanie Sarantopoulos, MD PhD, Joseph Pidala, MD PhD, Mary E. Flowers, MD, Philip L. McCarthy, MD, Mukta Arora, MD, Corey Cutler, MD MPH, FRCPC, William A. Wood, MD MPH, Alex Ganetsky, PharmD, Gregory A. Abel, MD, Navneet S. Majhail, MD MS, Stephanie J Lee, MD MPH

Blood (2017) 130 (Supplement 1): 530.

https://doi.org/10.1182/blood.V130.Suppl_1.530.530

Published: 2017

Journal Articles

Infections and Immune System Impairment in Multiple Myeloma: Increasing Frequency of Serious Complications in the "Novel Agents Era"— a Retrospective Real Life Analysis

Lorenza Torti, PhD MD, Annamaria Morelli, MD, Francesco Bacci, MD, Paolo Di Bartolomeo, MD

Blood (2017) 130 (Supplement 1): 1875.

https://doi.org/10.1182/blood.V130.Suppl_1.1875.1875

Published: 2017

Journal Articles

Individualized Treatment Summaries and Survivorship Care Plans (SCPs) for Hematopoietic Cell Transplant (HCT) Survivors Reduces Cancer Treatment Distress in a Randomized, Multicenter Study

Blood (2017) 130 (Supplement 1): 331.

https://doi.org/10.1182/blood.V130.Suppl_1.331.331

Published: 2017

Journal Articles

Prospective Validation of the Peds Clot Clinical Decision Rule [Pdcr] in Hospital-Acquired Venous Thromboembolism: An Interim Analysis

Rachael F Schultz, BA, Soyang Kwon, PhD, Anjali Sharathkumar, MD MS, Rukhmi Bhat, MD MS

Blood (2016) 128 (22): 3812.

https://doi.org/10.1182/blood.V128.22.3812.3812

Published: 2016

Journal Articles

Epigenetic Silencing of Catalase Induces Accumulation of Reactive Oxygen Species in Chronic Lymphocytic Leukemia B Cells Leading to Activation of Axl: An Escape Strategy?

Guru P Maiti, PhD MSc, Sutapa Sinha, PhD, Justin C Boysen, Neil E. Kay, MD, Asish K Ghosh, PhD

Blood (2016) 128 (22): 4363.

https://doi.org/10.1182/blood.V128.22.4363.4363

Published: 2016

Journal Articles

Defibrotide for Prophylaxis of Hepatic Veno-Occlusive Disease in Pediatric Hematopoietic Stem Cell Transplantation: Subanalysis Data from an Open-Label, Phase III, Randomized Trial

Selim Corbacioglu, MD, Ansgar S. Schulz, MD, Petr Sedlacek, MD PhD, Bernd Gruhn, MD, Simone Cesaro, MD, Peter Bader, MD

Blood (2015) 126 (23): 4310.

https://doi.org/10.1182/blood.V126.23.4310.4310

Published: 2015

Journal Articles

The Probability of Invasive Fungal Infection Among Children with Persistent Febrile Neutropenia and Respiratory Viral Infection

Avigail Rein, MD, Nira Arad, MD, Moran Amit, MD, Ayelet Ben-Barak, MD, Yael Shachor- Meyouhas, MD, Imad Kassis, Professor MD, Myriam Weyl Ben-Arush, Professor MD

Blood (2014) 124 (21): 4120.

https://doi.org/10.1182/blood.V124.21.4120.4120

Published: 2014

Journal Articles

Identification Of Patients At High Risk Of Chronic Graft-Versus-Host Disease: Gvhd Prophylaxis

Gabriel Afram, MD, Jose Antonio Pérez Simón, MD, PhD, Mats Remberger, PhD, Teresa Caballero-Velázquez, MD, PhD, Rodrigo Martino, MD, PhD, Jose Luis Piñana, MD, Olle Ringden, MD, Albert Esquirol, MD, Dolores Caballero, MD, PhD, Irene Garcia, MD, Lucía López-Corral, MD, PhD, Jordi Sierra, Oriana López-Godino, Per T. Ljungman, MD, PhD, Jesus F San Miguel, MD, PhD, Hans Hagglund, MD PhD

Blood (2013) 122 (21): 4611.

https://doi.org/10.1182/blood.V122.21.4611.4611

Published: 2013

Journal Articles

Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) Eligible For High Dose Melphalan (HDM)

Blood (2013) 122 (21): 1873.

https://doi.org/10.1182/blood.V122.21.1873.1873

Published: 2013

Journal Articles

Development Of a Serum Biomarker Panel That Predicts Imminent Risk Of Multiple Myeloma (MM) Progression From Premalignancy

A Kate Sasser, PhD, Tineke Casneuf, PhD, Dhammika Amaratunga, PhD, Volha Tryputsen, PhD, Shaji K Kumar, MD, Vincent Rajkumar, MD, Brett Hall

Blood (2013) 122 (21): 3115.

https://doi.org/10.1182/blood.V122.21.3115.3115

Published: 2013

Journal Articles

Intravenous Once-Daily BuCy 2 With Pharmacokinetic (PK)-Guided Dose Adjustment As Conditioning Regimen For AML Patients In First Complete Remission

Felipe Suarez, MD, Philippe Bourget, PhD, Emilio Paolo Alessandrino, MD, Mario Regazzi, PhD, Gérard Socié, MD, PhD, Mauricette Michallet, MD, PhD, Jérôme Guitton, PHD, Sebastien Wittnebel, MD, Angelo Paci, PHD, Didier Blaise, MD, Bénédicte Devictor, PHD, Ana Berceanu, MD, Véronique Kemmel, PHD, Jorge Sierra, MD, PhD, Maria Estela Moreno Martinez, PHD, Ambroise Marcais, MD, Alexandre Amin, PHD, Anna Amelia Colombo, MD, Francesco Ripamonti, MD, de Latour Régis Peffault, MD, Nathalie Dhedin, MD, Alienor Xhaard, MD, Hélène Labussière-Wallet, MD, Franck E Nicolini, MD, PhD, Marie Y. Detrait, MD, Sophie Ducastelle, MD, Xavier Thomas, MD, Jean-Henri Bourhis, MD, PhD, Gonzalo Ferrini, PHD, Sabine Furst, MD, Bruno Lioure, MD, Rodrigo Martino, MD, PhD, Mireia Riba, PH, Anna Feliu, PHD, Carole Levrault, Marcello Riggi, MD, PhD, Christine Ta Thanh Minh, MD

Blood (2013) 122 (21): 4566.

https://doi.org/10.1182/blood.V122.21.4566.4566

Published: 2013

Journal Articles

Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) In The Era Of New Agents Namely On ISS Stage II Patients

Blood (2013) 122 (21): 3150.

https://doi.org/10.1182/blood.V122.21.3150.3150

Published: 2013

Journal Articles

ARL-IPI - A New Prognostic Score for AIDS-Related Lymphomas in the Rituximab Era

Stefan K Barta, MD, MS, MRCP, Xiaonan Xue, Ph.D., Dan Wang, MS, Jeannette Y Lee, Ph.D., Lawrence D. Kaplan, MD, Josep-Maria Ribera, MD, PhD, Albert Oriol, Olga Garcia, Mireia Morgades, Michele Spina, MD, Umberto Tirelli, MD, Francois Boue, MD, PhD, Wyndham H. Wilson, MD, PhD, Christoph Wyen, MD, Kieron Dunleavy, MD, Joseph A Sparano, MD

Blood (2012) 120 (21): 1564.

https://doi.org/10.1182/blood.V120.21.1564.1564

Published: 2012

NARROW

Cytoreductive Treatment in 'Real Life' - Interim-Analysis of 434 Polycythemia Vera Patients in Germany

Flow-Cytometry Based Detection of Any Minimal Residual Disease (FC-MRD) in Children with T-Acute Lymphoblastic Leukemias (T-ALL) Is a Powerful Indicator of Outcome

Osteopontin Mediates Murine Transfusion-Related Acute Lung Injury through Stimulation of Pulmonary Neutrophil Accumulation

Observations from the First 1,000 Suspected aHUS Patients, Tested By a Rapid aHUS Genetic (NGS) Panel: Causative Genes Identified in a Subpopulation of Our Database

Area-Based Socioeconomic Status and Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Outcomes: A CIBMTR Analysis

Gastrointestinal Flora Dictates the Biological Response in Murine Transfusion Related Acute Lung Injury (TRALI)

Development of a Dynamic Model for Personalized Risk Assessment in Large B-Cell Lymphoma

Prevalence and Risk-Factors for Financial Burden in Patients with Chronic Graft-Versus-Host Disease: A Cross-Sectional Survey from the Chronic Gvhd Consortium

Infections and Immune System Impairment in Multiple Myeloma: Increasing Frequency of Serious Complications in the "Novel Agents Era"— a Retrospective Real Life Analysis

Individualized Treatment Summaries and Survivorship Care Plans (SCPs) for Hematopoietic Cell Transplant (HCT) Survivors Reduces Cancer Treatment Distress in a Randomized, Multicenter Study

Prospective Validation of the Peds Clot Clinical Decision Rule [Pdcr] in Hospital-Acquired Venous Thromboembolism: An Interim Analysis

Epigenetic Silencing of Catalase Induces Accumulation of Reactive Oxygen Species in Chronic Lymphocytic Leukemia B Cells Leading to Activation of Axl: An Escape Strategy?

Defibrotide for Prophylaxis of Hepatic Veno-Occlusive Disease in Pediatric Hematopoietic Stem Cell Transplantation: Subanalysis Data from an Open-Label, Phase III, Randomized Trial

The Probability of Invasive Fungal Infection Among Children with Persistent Febrile Neutropenia and Respiratory Viral Infection

Identification Of Patients At High Risk Of Chronic Graft-Versus-Host Disease: Gvhd Prophylaxis

Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) Eligible For High Dose Melphalan (HDM)

Development Of a Serum Biomarker Panel That Predicts Imminent Risk Of Multiple Myeloma (MM) Progression From Premalignancy

Intravenous Once-Daily BuCy 2 With Pharmacokinetic (PK)-Guided Dose Adjustment As Conditioning Regimen For AML Patients In First Complete Remission

Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) In The Era Of New Agents Namely On ISS Stage II Patients

ARL-IPI - A New Prognostic Score for AIDS-Related Lymphomas in the Rituximab Era

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only